Hypercoagulable States and New Anticoagulants, An Issue of Hematology/Oncology Clinics of North America
2010
W B Saunders Co Ltd (Verlag)
978-1-4377-2529-2 (ISBN)
W B Saunders Co Ltd (Verlag)
978-1-4377-2529-2 (ISBN)
Addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. This title discusses new anticoagulants including oral Xa inhibitors, oral IIa inhibitors, and use of low molecular weight heparin to improve survival in cancer patients.
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the treatment of HIT, and use of low molecular weight heparin to improve survival in cancer patients.
This issue addresses hypercoagulable states, such as antiphospholipid antibody syndrome, cancer-associated thrombosis, and coagulopathy associated with sepsis. New anticoagulants discussed include oral Xa inhibitors, oral IIa inhibitors, agents for the treatment of HIT, and use of low molecular weight heparin to improve survival in cancer patients.
| Reihe/Serie | The Clinics: Internal Medicine |
|---|---|
| Zusatzinfo | Illustrations |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Gewicht | 350 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| ISBN-10 | 1-4377-2529-5 / 1437725295 |
| ISBN-13 | 978-1-4377-2529-2 / 9781437725292 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00
Buch | Softcover (2023)
Deutscher Ärzteverlag
CHF 41,95
